Santex weight loss injection: separating the claims from the clinical evidence

Why the MHRA licence is the starting point, not a formality

When a weight-loss injection is licensed by the MHRA it means the regulator has reviewed the manufacturing standards, the clinical trial data and the product's safety profile before a single pen reaches a patient. That process is why tirzepatide and semaglutide have recognised product information documents — the Summary of Product Characteristics — that prescribers and pharmacists rely on when assessing whether a medicine suits a particular person.

A name like "Santex" does not appear in the MHRA's licensed medicines database. That matters practically, not just technically: without a licence, there is no verified trial evidence, no agreed dosing schedule, no listed side effects, and no manufacturing quality assurance. UK weight-loss injections that are licensed carry all of those protections as a baseline.

The MHRA has been explicit on this point in its public guidance on GLP-1 medicines for weight loss: unlicensed products sold online, sometimes under unfamiliar brand names, pose real risks. Enforcement action through 2025 included the seizure of roughly 20 million doses of illegally traded weight-loss medicines (estimated street value around £45 million) and the raid of a counterfeit manufacturing site. The message from regulators is consistent: if you cannot verify a product on an official register, that is the primary warning sign.

What licensed injections have actually demonstrated in trials

The evidence base for licensed weight-loss injections is substantial. Tirzepatide was studied in the SURMOUNT programme, involving thousands of adults with obesity. In SURMOUNT-1, participants taking the highest dose achieved an average body-weight reduction of around 20–21% over 72 weeks alongside a reduced-calorie diet and increased physical activity, according to the trial paper published in the New England Journal of Medicine. Semaglutide (Wegovy) produced an average reduction of approximately 15% over 68 weeks in the STEP 1 trial at the 2.4mg maintenance dose.

Both medicines work by mimicking gut hormones that regulate appetite and slow gastric emptying, reducing the drive to eat without relying on stimulants or fat-blocking mechanisms. Tirzepatide acts on two receptors (GIP and GLP-1) making it the only dual-agonist in this class licensed in the UK, and if you want a fuller picture of how these weight loss injections compare and what to expect from treatment, that detail is worth understanding before starting. These are meaningful distinctions, rooted in peer-reviewed evidence, and they are why NICE formally recommended both treatments through its technology appraisal process.

No equivalent evidence exists for any product called Santex. Searching for an injection under that name and finding UK suppliers is itself a red flag worth taking seriously.

Who the licensed injections are actually prescribed for

Eligibility for Mounjaro and Wegovy follows the medicines' licensed criteria: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone does not determine suitability; a prescriber reviews the full clinical picture, including any other medicines and health conditions, before approving treatment.

Neither injection is licensed for use in under-18s, during pregnancy, while breastfeeding, or when trying to conceive. Women using oral contraceptives starting tirzepatide should add a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because of a potential effect on pill absorption, a detail the NHS England guidance on weight-management injections covers clearly.

If you are wondering whether an existing condition makes you ineligible, that question belongs in a consultation rather than a search engine. The frequently asked questions page covers some of the common clinical queries people bring before starting.

How to check that an online pharmacy is legitimate before going further

If you are considering a weight-loss injection and doing your research online, one practical step takes under two minutes: look up any pharmacy on the GPhC register at pharmacyregulation.org/registers. Every pharmacy dispensing prescription medicines legally in Great Britain must appear there. If a website offering weight-loss injections cannot be found on that register, stop.

It is also worth understanding that for a prescription medicine, the price comparison question is somewhat secondary. A lower price does not make an unlicensed product safe, and several people have been hospitalised after injecting counterfeit pens that contained insulin rather than the stated medicine. The cost context for weight-loss injections covers what legitimate private pricing typically involves, and what headline prices often leave out.

If you're ordering around a bank holiday or the end of the month (payday timings catch a lot of people out) it's worth checking dispatch cut-offs in advance, since same-day dispatch depends on orders arriving before 12pm on a working day. People researching costs on a limited income may also find it useful to read about accessing weight loss injections while unemployed, including what options and support may realistically be available.

At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber (a named clinician, not automated software) and medicines are dispensed from our own GPhC-registered pharmacy (registration number 9012878, verifiable at the GPhC register). Treatment is dispatched the same working day once approved, via free tracked delivery. You can read more about who we are and how our service works, or explore the weight-loss treatments we prescribe to understand what a genuine clinical pathway looks like before speaking to our prescribers. If you have come across references to a specific weight loss injection starting with R, or seen mentions of an injection referred to by the letter M, those pages explain what those products are and how they fit into the licensed landscape.